(including depreciation and amortization) in Q2/2017 was THB 81.71 million, an increase by THB 5.53 million or 7.26% (Q2/2016 : THB 76.18 million). An increase was primarily due to an increase in medical costs
amended) is less than 15 percent and the total size of transactions in the past 6 months is also less than 15 percent. The transaction is subject to usual regulatory approvals (including approval by the
, including the legal due diligence, use of the intellectual property in relation to the project and the execution of the shareholders agreement, provided however that the Transaction will be completed within
to 507.94 million baht) due to an increase of sales expenses in proportion to the extra sales volume. Financial expenses including interest and bank fees also decreased by 3.66 million baht as the
securities or derivatives for the business operator’s proprietary trading including the business operator’s internal report relating to such investment, for no less than five years from the date the investment
securities or derivatives for the business operator’s proprietary trading including the business operator’s internal report relating to such investment, for no less than five years from the date the investment
securities or derivatives for the business operator’s proprietary trading including the business operator’s internal report relating to such investment, for no less than five years from the date the investment
, securities financing, securities dealing or securities underwriting which is not limited to debt instruments, but not including any company licensed to undertake securities business in the category of
, securities financing, securities dealing or securities underwriting which is not limited to debt instruments, but not including any company licensed to undertake securities business in the category of
in the category of securities brokerage, securities financing, securities dealing or securities underwriting which is not limited to debt instruments, but not including any company licensed to